Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CUSTOM: OTC Lovastatin Consumer Use Study
NCT00092846Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Dec 2002
- Primary completion
- Sep 2003
- Modality
- Small Molecules
01
Overview
Phase 3, open-label, single-arm trial of lovastatin in hypercholesterolemia, sponsored by Merck & Co. Primary endpoint: Percentage of patients who make appropriate decision for self-management. Started Dec 2002; status: completed.
02
Drugs
lovastatin
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT00092846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00092846.